Research Article | DOI: https://doi.org/10.31579/2639-4162/282
*Corresponding Author: Bugaevsky KA, Department of Medical and Biological Foundations of Sports and Physical Rehabilitation, The Petro Mohyla Black Sea State University, Nikolaev, Ukraine.
Citation: Konstantin A. Bugaevsky, (2025), History of the Discovery and Production of "Aspirin", In Reflection of the Means of Philately and Philocarty, J. General Medicine and Clinical Practice, 8(8); DOI:10.31579/2639-4162/282
Copyright: © 2025, Konstantin Anatolyevich Bugaevsky. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 12 June 2025 | Accepted: 07 August 2025 | Published: 14 August 2025
Keywords: aspirin; philately; postage stamps; envelopes; blocks; philocarty; postcards and art cards; screenshot copies
This article contains the materials of the conducted research, thematically related to the reflection of the issue of discovery and production of aspirin (acetylsalicylic acid), in the reflection of philatelic means: on postage stamps and envelopes, postal blocks, in philocarty (postal, art and educational cards), different countries of the world and the years of their issue and, different countries of the world. In total, this research article presents 46 screenshot copies of collection materials, of which - 29 philatelic and 17 philocarty.aspirin; philately; postage stamps; envelopes; blocks; philocarty; postcards and art cards; screenshot copies
Any scientific research related to medicine and pharmacy, their history and heroes, are always relevant and in demand. This directly concerns the issue of the history and heroes of the discovery of such a world-famous drug as aspirin, since the day of its discovery, about 127 years have passed. Of particular interest is the fact that this history will be presented to the reader with the help of such means of collecting as philately and philocarty, in all their diversity. According to existing and presented in a number of studies earlier, by other authors-researchers [1-4], the first mention of antipyretic and anti-inflammatory properties was written on ancient Sumerian tablets, and Hippocrates and other healers in ancient times knew about these properties of willow bark and branches. Another ancient Egyptian papyrus described these properties in 1543 BC, mentioning medicines made from willow bark. Hippocrates also used willow and its bark, and the Roman physician Aulus Cornelius Celsus directly said that willow bark extract helps with inflammation [1-4].
Back in 1763, a naturalist from Oxfordshire (England), Reverend Edward Stone (a local vicar), showed that dried in an oven and ground willow bark reduces high temperatures/heat. In 1828, a German researcher, Johann Buchner, also worked with willow bark extract, which he called "Salicin". Edward Stone gave a report on the treatment of feverish chills with willow bark tincture at the Royal Society of London. Later, in 1838, scientists found out that the active component of willow bark is salicylic acid [1-4]. This means that in the 19th century, to reduce fever, in the treatment of diseases, they again began to use white willow bark, which contains salicylic acid in its composition. But this method of treatment had a serious side effect, namely, abdominal pain and nausea. According to a number of historical data, around 1838, the Italian chemist and researcher Rafael Piria derived a stable formula for this substance. But salicylic acid had not yet received practical, medicinal use [1-4]. Some time after Edward Stone's research, the French chemist and researcher Charles Frederic Gerard was the first to obtain acetylsalicylic acid by reactions of acetyl chloride and sodium salicylate. He was able to synthesize this medicine, and, accordingly, to be the first to carry out the acetylation reaction of salicylic acid, in 1853, and obtained acetylsalicylic acid in its pure form [1-4]. This new substance was named “salicylic-acetic anhydride” by the French chemist Charles Frederic Gerhardt, and a little later it was named salicylic (“spiraic”) acid. Another six years passed, and another German chemist, von Glim, carried out a reaction between salicylic acid and acetyl chloride. The resulting crystals of this substance, von Glim called acetylierte Salicylsäure – acetylated salicylic acid. It took another decade (1869) for three more chemists – Schroeder, Prinzhorn and Kraut – to repeat the work of Gerhardt and von Glim and realize that they had obtained the same substance. In parallel, these three researchers were able to show the correct structure of the aspirin molecule (Figure 2) [1-4].

Figure 1: Chemical formula of acetylsalicylic acid
Thus, the drug became safe for use in medicine. Already in 1874, in Dresden, the first factory for the production of this drug was opened. By the end of the 19th century, the German scientist and researcher, Felix Hoffman, worked on the creation of chemically pure salicylic acid in a stable form, which he received a patent on March 6, 1899 (Figure 2). An interesting historical fact is that, being a chemist for the German company Bayer AG, F. Hoffman, on March 6, 1899, received an American patent in the United States, because, for a number of reasons, it was not immediately possible to patent the method for producing acetylsalicylic acid in the form of the drug "aspirin" in Germany, the homeland of F. Hoffman and the Bayer company, and this chemical and pharmaceutical company did not want to delay the release of a new promising drug [1-4].

Figure 2: Felix Hoffman and aspirin from Bayer AG
Initially, aspirin was produced in powder form, but since 1904, it has acquired the form of a tablet, which has become the most famous and most widespread tablet in the world, which for more than 127 years, successfully reduces fever and relieves pain in billions of people around the world. In the 1970s of the twentieth century, the role of aspirin in reducing the risk of vascular thrombosis, including coronary and cerebral arteries, was proven. Accordingly, aspirin became a medicine for the prevention of heart attacks, ischemic strokes and a whole bunch of cardiovascular diseases. In 1982, this discovery was noted by the Nobel Prize. This is the same aspirin that we know, and to this day we use it. Aspirin, or rather, the active substance of the drug - acetylsalicylic acid, is on the list of essential drugs of the World Health Organization, and also on the list of vital and essential drugs [1-4].
The purpose of writing this article by the author, based on the materials of his research, is to present to his readers an analysis of the research material, as well as the obtained volume of available philatelic materials, thematically related to the discovery and production of such a world-famous and popular drug as "aspirin" (the active ingredient is acetylsalicylic acid).
In conducting his research and subsequent writing of his article based on its materials, the author used such research methods as: literary-critical analysis of all available sources of information, both domestic and foreign, which were thematically devoted to the issue being studied by the author. First of all, these were research articles by a number of others by the author, information on the history of chemistry and pharmacy, available materials posted on websites and Internet pages of publications on such types of collecting as philately and philocarty. Also, all thematic, illustrative materials obtained as a result of search work on the Internet, with the help of special computer programs, were converted into color and black-and-white screenshot copies, which were then inserted directly into the text of this article as illustrations, supplied with brief accompanying material and appropriate links to the sources of their borrowing, to comply with the copyrights of their owners on the Internet.
I would like to begin my story about the history of the discovery and production process of aspirin by presenting a small selection of postage stamps, shown in Figure 3, from countries such as Colombia (1999), for the 100th anniversary of the discovery of aspirin; Liberia (2023), the Republic of Niger (2023), the Republic of Sierra Leone (2024), and Germany (1990), dedicated to this drug and the 100th and 125th anniversaries of its discovery and the start of industrial production [5-14].


Figure 3: A selection of postage stamps from a number of countries around the world dedicated to aspirin
Further, in a small selection of postage stamps of such countries as Liberia (2023), the Republic of Niger (2023), the Central African Republic (2024), dedicated to this drug and the 125th anniversary of its discovery and the beginning of industrial production, presented in Figure 4, portraits and situational drawings are depicted, thematically dedicated to the scientist who discovered aspirin - a German scientist, chemist and pharmacologist, which gave rise to the industrial production of this drug, a large German pharmaceutical corporation "BAYER", which produces aspirin, starting in 1899 - 126 years and, to this day, Felix Hoffmann / Felix Hoffmann (1868-1946) [5-14].

Figure 4: A selection of fidelitical materials dedicated to Felix Hofmann
Also, in Figure 5, another philatelic collection (postage stamps, postal block, envelopes) and philocartical (a series of postcards) of different years of issue are presented, which are thematically dedicated to aspirin and its use for medicinal purposes [15-21, 32].



Figure 5: Philatelic and philocartic collections dedicated to aspirin
Further, in Figure 6, a very interesting thematic, philocartical selection of art cards is presented, which was used in France, dedicated to aspirin and, in particular, to advertising its use. This was a very successful marketing move, which became a passion for hundreds, if not thousands of people! On the proposed art cards, which were often used as insert cards in a chocolate bar and included in their price, on their front side (obverse), at a very high artistic level, historical and biographical plots were presented, dedicated to famous doctors and a number of scientists of past years, their portraits, and on the back of this art card, their biography was presented, and also, a large place on their back was occupied by advertising aspirin and indications for its use, and a diagram/diary for recording the intake of aspirin tablets [22-31]. In total, this collection features 9 such artistic cards (although there are many more), dedicated to such personalities as Hippocrates, Bichat, Claude Bernard, Edward Jenner, Louis Pasteur, Alexander Fleming, William Harvey and Ambroise Paré – famous doctors of their time. There are also similar cards dedicated to a number of famous scientists, famous in other branches of science, as well as such areas as different types of transport, military events, airplanes and religious themes, with aspirin advertisements on their reverses.



Figure 6: A philocartical collection of postcards dedicated to a number of famous scientists and aspirin
This concludes another article devoted to the issue of discovery and production of aspirin (acetylsalicylic acid), in the reflection of various means of collecting, such as, in particular, philately and philocarty. The author is preparing for publication his new research article, thematically devoted to pharmacy, pharmacology and pharmacognosy, in the reflection of a number of various means of collecting.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,